INmune Bio Inc INMB:NASDAQ

Last Price$9.12NASDAQ Previous Close - Last Trade as of 3:59PM ET 8/11/22

Today's Change-0.21(2.25%)
Bid (Size)$8.36 (3)
Ask (Size)$15.08 (1)
Day Low / High$9.05 - 9.74
Volume39.8 K
 

View Biotechnology IndustryPeer Comparison as of 08/11/2022

 

INmune Bio Inc ( NASDAQ )

Price: $9.12
Change: -0.21 (2.25%)
Volume: 39.8 K
3:59PM ET 8/11/2022
 
 

CEL-SCI Corp ( NYSE MKT LLC )

Price: $4.00
Change: +0.11 (2.83%)
Volume: 565.6 K
8:00PM ET 8/11/2022
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

La Jolla Pharmaceutical Co ( NASDAQ )

Price: $6.20
Change: 0.00 (0.00%)
Volume: 56.9 K
4:00PM ET 8/11/2022
 
 

Precision BioSciences Inc ( NASDAQ )

Price: $1.63
Change: -0.02 (1.21%)
Volume: 1.5 M
4:00PM ET 8/11/2022
 

Read more news Recent News

-- Earnings Flash (INMB) INMUNE BIO Reports Q2 Revenue $16,000
4:33PM ET 8/03/2022 MT Newswires

...

-- Earnings Flash (INMB) INMUNE BIO Posts Q2 Loss $-0.38
4:32PM ET 8/03/2022 MT Newswires

...

INmune Bio Receives US Patent Covering Use of Central Nervous System Diseases Treatment
9:36AM ET 6/22/2022 MT Newswires

INmune Bio (INMB) said Wednesday that it has been issued a US patent covering the use of dominant negative tumor necrosis factor compositions by peripheral...

Sector Update: Health Care Stocks Returning to Positive Ground in Late Trade
4:01PM ET 5/24/2022 MT Newswires

Health care stocks were narrowly higher this afternoon, with the NYSE Health Care Index climbing less than 0.1% and the SPDR Health Care Select Sector ETF...

Company Profile

Business DescriptionINmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL. View company web site for more details
Address225 NE Mizner Boulevard
Boca Raton, Florida 33432
Phone+1.858.964.3720
Number of Employees3
Recent SEC Filing08/04/20228-K
Chairman, President, Chief Executive Officer & CMORaymond J. Tesi
Chief Financial Officer, Secretary & TreasurerDavid J. Moss
Chief Scientific & Manufacturing OfficerMark Lowdell
Associate General CounselJoshua S. Schoonover

Company Highlights

Price Open$9.38
Previous Close$9.12
52 Week Range$4.63 - 30.37
Market Capitalization$163.7 M
Shares Outstanding17.9 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/02/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.86
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit Margin-9,233.15%
Return on Equity-41.87%

Analyst Ratings as of 05/23/2022

Buy
2
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset